Matthew Ng Selected Research

Matthew Ng Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 06/2012
4	Wounds and Injuries (Trauma) 01/2022 - 08/2020
3	Peritonitis 03/2019 - 09/2007
3	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 07/2005
2	Hemorrhage 01/2022 - 05/2006
2	Ascites 01/2022 - 01/2022
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 05/2006
2	Ventricular Fibrillation 01/2013 - 07/2005
1	Crohn Disease (Crohn's Disease) 01/2022
1	Sepsis (Septicemia) 01/2022
1	Neutropenia 01/2022
1	Diverticulitis 01/2022
1	Diarrhea 01/2022
1	Wound Infection (Wound Infections) 01/2022
1	Adenocarcinoma 01/2022
1	Granuloma 01/2020
1	Endometrial Neoplasms (Endometrial Cancer) 12/2019
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2019
1	Breast Neoplasms (Breast Cancer) 12/2019
1	Traumatic Brain Injuries (Traumatic Brain Injury) 08/2019
1	Barotrauma 03/2019
1	Fatigue 09/2016
1	Anemia 09/2016
1	Stomach Neoplasms (Stomach Cancer) 08/2015
1	Necrosis 06/2012
1	Colonic Diverticulosis 03/2010
1	Peptic Ulcer (Peptic Ulcers) 05/2006
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2006
1	Ventricular Tachycardia 07/2005
1	Sudden Death 07/2005
1	Heart Failure 07/2005
1	Cardiotoxicity 07/2005
1	Stroke (Strokes) 06/2005
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 06/2005
1	Atrial Fibrillation 06/2005
1	Abdominal Pain (Pain, Abdominal) 10/2004
1	Cholangitis 10/2003
1	Pyogenic Liver Abscess 09/2002
1	Liver Abscess 09/2002
1	Chills 09/2002
1	Fever (Fevers) 09/2002

Drug/Important Bio-Agent (IBA)

2	Capecitabine (Xeloda)FDA Link 01/2022 - 07/2005
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2017
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2016 - 07/2005
2	Fluorouracil (Carac)FDA LinkGeneric 09/2016 - 08/2015
1	CholesterolIBA 01/2020
1	Estrogen ReceptorsIBA 12/2019
1	AlpelisibIBA 12/2019
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 12/2019
1	infigratinibIBA 12/2019
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 08/2019
1	AnticoagulantsIBA 08/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Complement System Proteins (Complement)IBA 01/2017
1	Biological ProductsIBA 01/2017
1	Leucovorin (Folinic Acid)FDA Link 09/2016
1	Irinotecan (Camptosar)FDA LinkGeneric 09/2016
1	EnzymesIBA 09/2016
1	afliberceptIBA 09/2016
1	ErbB Receptors (EGF Receptor)IBA 08/2015
1	Trastuzumab (Herceptin)FDA Link 08/2015
1	Monoclonal AntibodiesIBA 08/2015
1	Cisplatin (Platino)FDA LinkGeneric 08/2015
1	PlatinumIBA 08/2015
1	Proteins (Proteins, Gene)FDA Link 08/2015
1	Saline SolutionIBA 01/2013
1	Erythropoietin FDA Link 01/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2012
1	fosbretabulin (combretastatin A4)IBA 06/2012
1	Bevacizumab (Avastin)FDA Link 06/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2007
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2006
1	Troponin IIBA 07/2005
1	Clopidogrel (Plavix)FDA Link 06/2005
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 06/2005
1	lysyl- lysyl- leucyl- phenylalanyl- lysyl- lysyl- isoleucyl- leucyl- lysyl- tyrosyl- leucinamideIBA 10/2004
1	PlasticsIBA 10/2003
1	Alkaline PhosphataseIBA 09/2002

Therapy/Procedure

4	Therapeutics 01/2022 - 06/2005
2	Minimally Invasive Surgical Procedures 01/2022 - 01/2022
2	Artificial Respiration (Mechanical Ventilation) 01/2022 - 01/2022
2	Bathroom Equipment 08/2020 - 03/2019
2	Resuscitation 08/2019 - 01/2013
2	Drug Therapy (Chemotherapy) 09/2016 - 08/2015
2	Secondary Prevention 05/2006 - 06/2005
2	Endoscopic Sphincterotomy 10/2003 - 09/2002
1	Operative Time 01/2022
1	Length of Stay 01/2022
1	Airway Management 01/2021
1	Sutures (Suture) 12/2020
1	Peritoneal Dialysis 03/2010
1	Antibiotic Prophylaxis 09/2007
1	Continuous Ambulatory Peritoneal Dialysis (CAPD) 09/2007
1	Stents 10/2003
1	Decompression 10/2003
1	Prostheses and Implants (Prosthesis) 10/2003